期刊文献+

比较黄体酮阴道缓释凝胶与黄体酮联合地屈孕酮对体外受精的黄体支持 被引量:8

To comparethe function of vaginal progesterone gel and Progesterone combining with dydrogesterone for luteal support after in vitro fertilization /intracytoplasmic sperm injection
原文传递
导出
摘要 目的探讨黄体酮阴道缓释凝胶与黄体酮联合地屈孕酮两种黄体支持方法对IVF-ET/ICSI术后不孕患者的妊娠结局影响。方法对200例进行IVF-ET/ICSI术的不孕患者进行回顾性分析,按取卵后不同的黄体支持方法分为两组,A组采用黄体酮阴道缓释凝胶进行黄体支持;B组采用黄体酮联合地屈孕酮进行黄体支持;结果 A、B组两组所获得的临床妊娠率、异位妊娠率、多胎妊娠率及早期流产率均无显著性差异(P>0.05),阴道黄体酮凝胶组不良反应较轻,两组妊娠患者早期出血率无明显差异(P>0.05)。结论采用黄体酮阴道缓释凝胶对行IVF-ET/ICSI术的不孕患者进行黄体支持与黄体酮联合地屈孕酮进行黄体支持所获得的妊娠结局是一致的,且其使用更方便,患者耐受性更好,在临床上可以单独应用黄体酮阴道缓释凝胶进行IVF-ET/ICSI术后的黄体支持。 Objective : To study the effect of vaginal progesterone gel and Progesterone combine with dydrogesterone for luteal support after in vitro fertilization/intracytoplasmic sperm. Methods: The data of 200 patients undergoing IVF - ET/ICSI after oocytes retrieved were retrospectively analyzed. The patients were divided into Group A (simple vaginal progesterone gel) with 100 cases, Group B (Progesterone combine with dydrogesterone) 100 cases according different supporting methods for the corepus luteum. Resuits: There were no significant differences in clinic pregnancy rate, the eetopic pregnancy rate, multiple pregnancy rate and the early abortion rate among two groups ( P 〉 0. 05 ). Adverse reaction is slighter in group A than in group B, There were no significant differences in the early bleeding rate among two groups ( P 〉 0. 05 ). Conclusion : Two projects had the same pregnancy outcome as the resuits of the patients undergoing IVF - ET, But vaginal progesterone gel are more convenient and easy to use, so it can be use for luteal support after IVF - ET/ICSI, alone.
出处 《中国优生与遗传杂志》 2013年第9期106-107,118,共3页 Chinese Journal of Birth Health & Heredity
关键词 辅助生殖技术 黄体期支持 黄体酮阴道缓释凝胶 黄体酮 地屈孕酮 IVF - ET/ICSI Luteal phase support Vaginal progesterone Progesterone Dydrogesterone
  • 相关文献

参考文献10

  • 1Fatemi I4M, Popovic - Todorovic B, Papanikolau E, et al. An update of luteal phase support in stimulated IVF cycles [ J ]. Hum Reprod Update,2007,13:581 - 90.
  • 2Pabuccu R, Ak ar ME. Luteal phase support in assisted reproductive technology[ J]. CurrOp in Obstet Gynecol,2005, 17 (3) : 277.
  • 3Polyzos NP, Messini CI, Papanikolaou EG, et al. Vaginal progester- one gel for luteal phase support in IVF/ICSI cycles: a meta -analysis [ J ]. Fertil Steri1,2010,94 (6) : 2083 - 2087.
  • 4Macklon NS, Fauser BC. Impact of ovarian hyperstimulation on theluteal phase[J]. Reprod Fertil Suppl,2000,55:101 - 108.
  • 5Tavan iotou A, Smitz J, Bourgain C, et al. Compariion between different mutes of pmgester on eadmin istration and luteal phase support in in fer- tility treatmentsIJ]. Hum Rep rod Update, 2000, 6(2): 139 -148.
  • 6覃桂荣,龙凤宜,蒋晓莉.益玛欣在体外受精—胚胎移植后先兆流产中的作用[J].中国优生与遗传杂志,2009,17(3):123-123. 被引量:8
  • 7黄卡立,檀大羡.3种黄体支持方法在体外受精-胚胎移植术后对妊娠结局的影响[J].中国计划生育和妇产科,2010,2(3):5-7. 被引量:10
  • 8Silverberg KM, Vaughn TC, Hansard LJ, et al. Vaginal (Crinone 8% ) gelversus intramuscular progesterone in oil for luteal phase sup- port in in vitro fertilization: a large prospective trial[ J]. Fertil Steril, 2012,97: 344 - 348.
  • 9Fanchin R, Righini G, Olivennes F, et al. Uterine contractions at the time of embryo transfer alter pregnancy rates after in vitro fertilization [J]. Hum Reprod,1998,13(7) : 1968 - 1974.
  • 10龚斐,蔡素芬,卢光琇.两种阴道给药黄体支持药物在IVF-ET/ICSI后用药的比较研究[J].实用妇产科杂志,2012,28(3):199-201. 被引量:21

二级参考文献15

  • 1李雪梅,赵坤,刘庆芝,李晓英,欧秀华,唐雪莲.地屈孕酮治疗先兆流产的临床观察[J].实用医学杂志,2007,23(8):1245-1246. 被引量:35
  • 2Vaniotou A, et al. Comparison between different routes of progesterone administration as luteal phase support in infertiliy treatments[ J]. Hum Rep rod Update, 2000, 6 (2) : 139-148.
  • 3Chakravarty BN,et d. Oral hydrogesterone as luted phase support in assisted reproductive technology (ART)cycles:results of randomized study [J]. J Steroid Biochem Mol Biol,2005,97 (5) :416 -420.
  • 4Pabuccu R. Akar ME1 Luteal phase support in assisted reproductive technology[ J]. Currop in Obstet Gynecol, 2005, 17 (3) : 277.
  • 5ChakravartyBN, Shirazee HH, Dam P, et al. Oral hydrogesterone versus intravaginal mieronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles : results of a randomised study [ J ]. Steroid Biochem Mol Biol, 2005,97 ( 5 ) : 416.
  • 6Fatemi HM, Popovie-Todorovic B, Papanikolaou E, et al. An update of luteal phase support in stimulated IVF cycles [ J ]. Hum Reprod Update, 2007,13 (6) :581 - 590.
  • 7Elena Yanushpolsky MD, Shelley Hurwitz PhD, Loasise Greenberg MEd, et al. Crinone vaginal gel is equally effective and better tolera- ted than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study [ J ]. Fertility and Sterility, 2010,94 ( 7 ) : 2596 - 2599.
  • 8Levy T, Yairi Y, Bar Hava I. Pharmacokinetics of the progesterone containing vaginal tablet and its use in assisted reproduction [ J ]. Steroids, 2000, 65 ( 10 - 11 ) : 645 - 649.
  • 9Fanchin R, Righini C, Olivennes F, et al. Uterine contractions at the time of embryo transfer alter pregnancy rates after in vitro fertilization [J]. Hum Reprod, 1998,13(7) :1968 -1974.
  • 10Ludwig M, Schwartz P, Babahan B, et al. Luteal phase support using either Crinone 8% or Utrogest :results of a prospective, random- ized study [ J ]. Obstetrics & Gynecology,2002,103 ( 1 ) :48 - 52.

共引文献33

同被引文献84

  • 1Balaban B, Urman B, Ata B, et al. A randomized controlled study of human Day 3 embryo cryoprescrvation by slow freezing or vitrification: vitrification is associated with higher survival, metabolism and blastocyst formation [ J ] . Hum Reprod, 2008,23 : 1976-1982.
  • 2Propst AM, Hill JA,Ginsburg ES, et al. A randomized study comparing Crinone 8 and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles[J]. Fertil Steril,2001,76 : 1144-1149.
  • 3Levy T,Yairi Y, Bar-Hava I, et al. Pharmacokinetics of the progesterone-containing vaginal tablet and its use in assisted reproduction[J]. Steroids, 2000,65 645-649.
  • 4Shapiro DB, Pappadakis JA, Ellsworth NM, et al. Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving Vitrified blastocysts [J] Hum Reprod, 2014, 29 : 1706-1711.
  • 5Silverberg KM, Vaughn TC, Hansard LJ, et al. Vaginal (Crinone 8)gel vs. intramuscular progesterone in oil, for luteal phase support in in vitro fertilization: a large prospective trial[J]. Fertil Steril,2012,97:344-348.
  • 6van der Linden M, Buckingham K, Farquhar C, et al. Luteal phase support for assisted reproduction cycles [J/CD]. Cochrane Database Syst Rev,2011, (10).-CD009154.
  • 7Patki A,Pawar VC. Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone[J]. Gynecol Endocrinol, 2007,23 (Suppl 1) : 68-72.
  • 8Hudi I,Szekeres-Bartho J, Fatugie Z, et al. Dydrogesterone supplementation in women with threatened preterm delivery-- the impact on cytokine pro{lie, hormone profile, and progesterone-induced blocking {actor[J]. J Reprod Immunol, 2011,92 103-107.
  • 9Kumar A, Begum N, Prasad S, et al. Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of eytokine production a double-blind, randomized, parallel, placebo- controlled trial[J]. Fertil Steril, 2014,102 : 1357-1363.
  • 10Szekeres-Bartho J,Polgar B. PIBF: the double edged sword. Pregnancy and tumor[J]. Am J Reprod Immunol, 2010,64 : 77-86.

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部